Literature DB >> 17082480

Altered Na+ channels promote pause-induced spontaneous diastolic activity in long QT syndrome type 3 myocytes.

Sandra Fredj1, Nicolas Lindegger, Kevin J Sampson, Peter Carmeliet, Robert S Kass.   

Abstract

Long QT syndrome (LQTS) type 3 (LQT3), typified by the DeltaKPQ mutation (LQT3 mutation in which amino acid residues 1505 to 1507 [KPQ] are deleted), is caused by increased sodium entry during the action potential plateau resulting from mutation-altered inactivation of the Na(v)1.5 channel. Although rare, LQT3 is the most lethal of common LQTS variants. Here we tested the hypothesis that cellular electrical dysfunction, caused not only by action potential prolongation but also by mutation-altered Na(+) entry, distinguishes LQT3 from other LQTS variants and may contribute to its distinct lethality. We compared cellular electrical activity in myocytes isolated from mice heterozygous for the DeltaKPQ mutation (DeltaKPQ) and myocytes from wild-type littermates. Current-clamp pause protocols induced rate-dependent spontaneous diastolic activity (delayed after depolarizations) in 6 of 7 DeltaKPQ, but no wild-type, myocytes (n=11) tested. Voltage-clamp pause protocols that independently control depolarization duration and interpulse interval identified a distinct contribution of both depolarization duration and mutant Na(+) channel activity to the generation of Ca(i)(2+)-dependent diastolic transient inward current. This was found at rates and depolarization durations relevant both to the mouse model and to LQT3 patients. Flecainide, which preferentially inhibits mutation-altered late Na(+) current and is used to treat LQT3 patients, suppresses transient inward current formation in voltage-clamped DeltaKPQ myocytes. Our results demonstrate a marked contribution of mutation-altered Na(+) entry to the incidence of pause-dependent spontaneous diastolic activity in DeltaKPQ myocytes and suggest that altered Na(+) entry may contribute to the elevated lethality of LQT3 versus other LQTS variants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082480      PMCID: PMC4454351          DOI: 10.1161/01.RES.0000251305.25604.b0

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  39 in total

1.  Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia.

Authors:  C E Clancy; Y Rudy
Journal:  Nature       Date:  1999-08-05       Impact factor: 49.962

2.  A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates.

Authors:  R Mitra; M Morad
Journal:  Am J Physiol       Date:  1985-11

3.  Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.

Authors:  Colleen E Clancy; Michihiro Tateyama; Robert S Kass
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  Cellular origins of the transient inward current in cardiac myocytes. Role of fluctuations and waves of elevated intracellular calcium.

Authors:  J R Berlin; M B Cannell; W J Lederer
Journal:  Circ Res       Date:  1989-07       Impact factor: 17.367

5.  Effect of calcium on acetylstrophanthidin-induced transient depolarizations in canine Purkinje tissue.

Authors:  G R Ferrier; G K Moe
Journal:  Circ Res       Date:  1973-11       Impact factor: 17.367

6.  Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Authors:  P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

7.  Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness.

Authors:  S M Pogwizd; K Schlotthauer; L Li; W Yuan; D M Bers
Journal:  Circ Res       Date:  2001-06-08       Impact factor: 17.367

8.  Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?

Authors:  J Benhorin; R Taub; M Goldmit; B Kerem; R S Kass; I Windman; A Medina
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

9.  Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine.

Authors:  A I Undrovinas; I A Fleidervish; J C Makielski
Journal:  Circ Res       Date:  1992-11       Impact factor: 17.367

10.  Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

Authors:  Silvia G Priori; Carlo Napolitano; Peter J Schwartz; Massimiliano Grillo; Raffaella Bloise; Elena Ronchetti; Cinzia Moncalvo; Chiara Tulipani; Alessia Veia; Georgia Bottelli; Janni Nastoli
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

View more
  27 in total

1.  Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.

Authors:  Serge Sicouri; Jonathan Blazek; Luiz Belardinelli; Charles Antzelevitch
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-03-09

Review 2.  Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death.

Authors:  Stefan Wagner; Lars S Maier; Donald M Bers
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 3.  Pathophysiology of the cardiac late Na current and its potential as a drug target.

Authors:  Jonathan D Moreno; Colleen E Clancy
Journal:  J Mol Cell Cardiol       Date:  2011-12-16       Impact factor: 5.000

4.  Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.

Authors:  Franck Potet; Thomas M Beckermann; Jennifer D Kunic; Alfred L George
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-05-28

5.  Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.

Authors:  Larissa Fabritz; Dierk Damke; Markus Emmerich; Susann G Kaufmann; Kathrin Theis; Andreas Blana; Lisa Fortmüller; Sandra Laakmann; Sven Hermann; Elena Aleynichenko; Johannes Steinfurt; Daniela Volkery; Burkhard Riemann; Uwe Kirchhefer; Michael R Franz; Günter Breithardt; Edward Carmeliet; Michael Schäfers; Sebastian K G Maier; Peter Carmeliet; Paulus Kirchhof
Journal:  Cardiovasc Res       Date:  2010-01-28       Impact factor: 10.787

Review 6.  The cardiac persistent sodium current: an appealing therapeutic target?

Authors:  D A Saint
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

Review 7.  Na⁺ transport in the normal and failing heart - remember the balance.

Authors:  Sanda Despa; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2013-04-19       Impact factor: 5.000

8.  Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazine.

Authors:  N Lindegger; B M Hagen; A R Marks; W J Lederer; R S Kass
Journal:  J Mol Cell Cardiol       Date:  2009-04-14       Impact factor: 5.000

9.  Ranolazine for congenital and acquired late INa-linked arrhythmias: in silico pharmacological screening.

Authors:  Jonathan D Moreno; Pei-Chi Yang; John R Bankston; Eleonora Grandi; Donald M Bers; Robert S Kass; Colleen E Clancy
Journal:  Circ Res       Date:  2013-07-29       Impact factor: 17.367

Review 10.  The arrhythmogenic consequences of increasing late INa in the cardiomyocyte.

Authors:  John C Shryock; Yejia Song; Sridharan Rajamani; Charles Antzelevitch; Luiz Belardinelli
Journal:  Cardiovasc Res       Date:  2013-06-10       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.